803 related articles for article (PubMed ID: 26703802)
1. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
Kruglyak KM; Lin E; Ong FS
Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
[TBL] [Abstract][Full Text] [Related]
2. Personalized Therapy of Non-small Cell Lung Cancer (NSCLC).
Gadgeel SM
Adv Exp Med Biol; 2016; 890():203-22. PubMed ID: 26703806
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
5. microRNA and Lung Cancer.
Del Vescovo V; Denti MA
Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
[TBL] [Abstract][Full Text] [Related]
6. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
7. [Lung Cancer].
Yoshida K; Kono T
Gan To Kagaku Ryoho; 2016 Nov; 43(11):1321-1325. PubMed ID: 27899772
[TBL] [Abstract][Full Text] [Related]
8. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.
Wijesinghe P; Bollig-Fischer A
Adv Exp Med Biol; 2016; 890():1-23. PubMed ID: 26703796
[TBL] [Abstract][Full Text] [Related]
10. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
11. NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?
Falk AT; Heeke S; Hofman V; Lespinet V; Ribeyre C; Bordone O; Poudenx M; Otto J; Garnier G; Castelnau O; Guigay J; Leroy S; Marquette CH; Hofman P; Ilié M
Expert Rev Anticancer Ther; 2017 Aug; 17(8):681-685. PubMed ID: 28511612
[TBL] [Abstract][Full Text] [Related]
12. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
Shimazawa R; Ikeda M
Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine.
Coco S; Truini A; Vanni I; Dal Bello MG; Alama A; Rijavec E; Genova C; Barletta G; Sini C; Burrafato G; Biello F; Boccardo F; Grossi F
Curr Drug Targets; 2015; 16(1):47-59. PubMed ID: 25495923
[TBL] [Abstract][Full Text] [Related]
14. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing and Immunotherapy Biomarkers: A Medical Oncology Perspective.
Bernicker E
Arch Pathol Lab Med; 2016 Mar; 140(3):245-8. PubMed ID: 26927719
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing for lung cancer.
Wu K; Huang RS; House L; Cho WC
Future Oncol; 2013 Sep; 9(9):1323-36. PubMed ID: 23980680
[TBL] [Abstract][Full Text] [Related]
18. Gene mutation-based and specific therapies in precision medicine.
Wang X
J Cell Mol Med; 2016 Apr; 20(4):577-80. PubMed ID: 26994883
[TBL] [Abstract][Full Text] [Related]
19. Targeting HER2 in the treatment of non-small cell lung cancer.
Mar N; Vredenburgh JJ; Wasser JS
Lung Cancer; 2015 Mar; 87(3):220-5. PubMed ID: 25601485
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer.
Yeung KT; More S; Woodward B; Velculescu V; Husain H
Mol Diagn Ther; 2017 Aug; 21(4):375-384. PubMed ID: 28337711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
